Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Gamida Cell Ltd.
DescriptionUmbilical cord blood-derived ex vivo nicotinamide-expanded stem cell graft
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Stem cell
Latest Stage of DevelopmentPhase I/II
Standard Indication Hematology (unspecified)
Indication DetailsTreat sickle cell disease or thalassemia major
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today